ASMC'13 Moscow
Conferences > Archives > ASMC'13 Moscow

Confirmed Speakers


Confirmed Speakers to date

Synthetic Organic Photochemistry in Batch and Flow
Prof. Kevin BOOKER-MILBURNProf. Kevin BOOKER-MILBURN
(UNIVERSITY OF BRISTOL, Bristol, United Kingdom)

Read more
Making Molecular Prosthetics via Iterative Cross-Coupling with MIDA Boronates
Prof. Martin D. BURKEProf. Martin D. BURKE
(UNIVERSITY OF ILLINOIS, Urbana, United States)

Read more
Oligonucleotide Synthesis Interfaced with Molecular Biology and Nanotechnology
Prof. Marvin CARUTHERSProf. Marvin CARUTHERS
(UNIVERSITY OF COLORADO, Boulder, United States)

Read more
BETting on Epigenetic Targets : From Phenotypic Discovery to First Time in Man
Dr Chun-wa CHUNGDr Chun-wa CHUNG
(GLAXOSMITHKLINE, Stevenage, United Kingdom)

Read more
Versatile Synthetic Methods: Access to Bioactive Molecules
Prof. Janine COSSYProf. Janine COSSY
(ESPCI PARISTECH, Paris, France)

Read more
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture
Dr Simona COTESTADr Simona COTESTA
(NOVARTIS, Basel, Switzerland)

Read more
Highly Anti-inflammatory Dendritic Polyglycerol Sulfates - a Multiple Target Approach
Prof. Rainer HAAGProf. Rainer HAAG
(FREE UNIVERSITY BERLIN, Berlin, Germany)

Read more
Targeting Protein Surfaces Using Designed Proteomimetics
Prof. Andrew HAMILTONProf. Andrew HAMILTON
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)

Read more
A New Approach to Tuberculosis Research: The Lilly TB Drug Discovery Initiative
Dr Philip A. HIPSKINDDr Philip A. HIPSKIND
(ELI LILLY & COMPANY, Indianapolis, United States)

Read more
Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to the Clinical Candidate AZD7687
Dr Petra JOHANNESSONDr Petra JOHANNESSON
(ASTRAZENECA, Mölndal, Sweden)

Read more
Harnessing Synergy Between Natural Products and Synthesis Towards Drug Discovery
Prof. Goverdhan MEHTAProf. Goverdhan MEHTA
(UNIVERSITY OF HYDERABAD, Hyderabad, India)

Read more
New Strategies in Organic Synthesis: Recent Advances Based on Catalytic Reactions of Boron Reagents
Prof. James P. MORKENProf. James P. MORKEN
(BOSTON COLLEGE, Chestnut Hill, United States)

Read more
P2X Receptors: ATP-Gated Ion Channels as Novel Drug Targets
Prof. Christa MÜLLERProf. Christa MÜLLER
(UNIVERSITY OF BONN, Bonn, Germany)

Read more
Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules
Dr Antonio NARDIDr Antonio NARDI
(GRÜNENTHAL, Aachen, Germany)

Read more
Organic Molecules as Biological Probes...an exciting journey
Prof. Cristina NEVADOProf. Cristina NEVADO
(UNIVERSITY OF ZURICH, Zurich, Switzerland)

Read more
Bitopertin (RG1678), a Potent and Selective Glycine Re-Uptake Inhibitor for the Treatment of Schizophrenia
Dr Emmanuel PINARDDr Emmanuel PINARD
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)

Read more
Antibody Drug Conjugates for the Treatment of Cancer
Dr Paul POLAKISDr Paul POLAKIS
(GENENTECH, San Francisco, United States)

Read more
Peptide Chemologics
Dr Lee ROBERTSDr Lee ROBERTS
(PFIZER, Sandwich, United Kingdom)

Read more
The Discovery of the Macrocyclic HCV NS3/4A Protease Inhibitor MK-5172
Dr Michael ROWLEYDr Michael ROWLEY
(MERCK RESEARCH LABORATORIES, Kriens, Switzerland)

Read more
The Design and Characterization of Targeted Covalent Inhibitors of Btk
Dr Eric SCHWARTZDr Eric SCHWARTZ
(CELGENE AVILOMICS RESEARCH, Cambridge, United States)

Read more
From Organic Synthesis to Biomedical Sciences - from Polyhydroxybutyrate (PHB) to Cell-Penetrating Peptides
Prof. Dieter SEEBACHProf. Dieter SEEBACH
(ETH ZURICH, Zürich, Switzerland)

Read more
Engineering of Small Non-Antibody Protein Scaffolds as Novel Biopharmaceuticals: from Anticalins to PASylation
Prof. Arne SKERRAProf. Arne SKERRA
(TECHNICAL UNIVERSITY MUNICH, München, Germany)

Read more
Metal Catalyzed Arylation of Nucleophiles
Dr Marc TAILLEFERDr Marc TAILLEFER
(ENSCM, Montpellier, France)

Read more
Discovery and Initial Clinical Results of [18F]-UCB-H, First PET Radiotracer Targeting Synaptic Vesicle 2A
Dr Anne VALADEDr Anne VALADE
(UCB, Braine-l'Alleud, Belgium)

Read more

Confirmed Oral Communications

EFMC Prize for a Young Medicinal Chemist in Academia
Chemical Approaches to Biology and Therapeutics
Dr Goncalo BERNARDESDr Goncalo BERNARDES
(INSTITUTO DE MEDICINA MOLECULAR, PORTUGAL & UNIVERSITY OF CAMBRIDGE, Lisbon, Portugal)

Read more
EFMC Prize for a Young Medicinal Chemist in Industry
Free-Wilson and Structural Approaches to Co-Optimising Human and Rodent Isoform Potency for 11β-Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors
Dr Frederick GOLDBERGDr Frederick GOLDBERG
(ASTRAZENECA, Macclesfield, United Kingdom)

Read more
Novel Synthetic Chemical Chaperones as a New Basis For Amyotrophic Lateral Sclerosis (ALS) Treatment
Prof. Arie-Lev GRUZMANProf. Arie-Lev GRUZMAN
(BAR ILAN UNIVERSITY, Ramat Gan, Israel)

Read more
New Inhibitors of the Enzyme Isoprenylcysteine Carboxyl Methyltransferase (ICMT)
Prof. María del Mar MARTÍN-FONTECHAProf. María del Mar MARTÍN-FONTECHA
(COMPLUTENSE UNIVERSITY OF MADRID, Madrid, Spain)

Read more
Fragment-Based Design of Inhibitors of The Antituberculotic Target 1-Deoxy-D-Xylulose-5-Phosphate Synthase Exploiting an Innovative Combination of NMR Techniques
Mrs Tiziana MASINIMrs Tiziana MASINI
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands)

Read more
Design, Synthesis and Application Of Fluorinated Amino Acids as Labels to Study the Membrane Active Peptides by Solid State 19F NMR
Dr Pavel MYKHAILIUKDr Pavel MYKHAILIUK
(ENAMINE LTD, Kyiv, Ukraine)

Read more
Rapid Kinase SAR Generation: an Integrated Approach to Synthesis, Screening and Molecular Design
Dr David PARRYDr David PARRY
(CYCLOFLUIDIC LTD, United Kingdom)

Read more
Virtual Screening and Design of New Pharmaceutical Agents Using PASS Approach
Prof. Vladimir POROIKOVProf. Vladimir POROIKOV
(INSTITUTE OF BIOMEDICAL CHEMISTRY, Moscow, Russia)

Read more
Discovery of Highly Potent S1P1 Receptor Antagonists with in vivo Efficacy
Dr Jean QUANCARDDr Jean QUANCARD
(NOVARTIS, Basel, Switzerland)

Read more
Self-Immolative Spacers in Prodrug/Profluorophore Strategies: Determination of Kinetic Parameters for Release of Single or Multiple Substrates.
Dr Frédéric SCHMIDTDr Frédéric SCHMIDT
(INSTITUT CURIE, Paris, France)

Read more
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b Inhibitors
Dr Graeme SMITHDr Graeme SMITH
(VERTEX PHARMACEUTICALS, Cambridge, United States)

Read more
Synthetic Approach to Novel Melatonin Receptor Ligands
Mrs Maria VOLKOVAMrs Maria VOLKOVA
(MOSCOW STATE UNIVERSITY, CHEMISTRY DEPARTMENT, Moscow, Russia)

Read more

Organized by

Silver Sponsors

Bronze Sponsors

Media Partners

Copyright 2019 LD Organisation sprl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys